[HTML][HTML] Extracellular vesicles as markers and mediators in sepsis

P Raeven, J Zipperle, S Drechsler - Theranostics, 2018 - ncbi.nlm.nih.gov
Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host
response to infection. It remains a highly lethal condition in which current tools for early …

Pathophysiology of trauma-induced coagulopathy

P Duque, A Calvo, C Lockie, H Schöchl - Transfusion medicine reviews, 2021 - Elsevier
There is no standard definition for trauma-induced coagulopathy (TIC). However, it could be
defined as an abnormal hemostatic response secondary to trauma. The terms “early TIC” …

[HTML][HTML] Biodistribution, pharmacokinetics, and blood compatibility of native and PEGylated tobacco mosaic virus nano-rods and-spheres in mice

MA Bruckman, LN Randolph, A VanMeter, S Hern… - Virology, 2014 - Elsevier
Understanding the pharmacokinetics, blood compatibility, biodistribution and clearance
properties of nanoparticles is of great importance to their translation to clinical application. In …

Role of extracellular vesicles in the development of sepsis-induced coagulopathy

T Iba, H Ogura - Journal of Intensive Care, 2018 - Springer
Background The advances of research on extracellular vesicles (EVs) are of particular
interest to the clinicians as well as the researchers who are studying coagulation disorder in …

“In less than no time”: feasibility of rotational thromboelastometry to detect anticoagulant drugs activity and to guide reversal therapy

V Pavoni, L Gianesello, D Conti, P Ballo… - Journal of Clinical …, 2022 - mdpi.com
Anticoagulant drugs (ie, unfractionated heparin, low-molecular-weight heparins, vitamin K
antagonists, and direct oral anticoagulants) are widely employed in preventing and treating …

Tissue factor is induced by interleukin-33 in human endothelial cells: a new link between coagulation and inflammation

S Stojkovic, C Kaun, J Basilio, S Rauscher, L Hell… - Scientific reports, 2016 - nature.com
Tissue factor (TF) is the primary trigger of coagulation. Elevated levels of TF are found in
atherosclerotic plaques and TF leads to thrombus formation when released upon plaque …

[PDF][PDF] Management of bleeding and transfusion during liver transplantation before and after the introduction of a rotational thromboelastometry–based algorithm

S Roullet, G Freyburger, M Cruc, A Quinart… - Liver …, 2015 - Wiley Online Library
Orthotopic liver transplantation (OLT) remains a potentially hemorrhagic procedure.
Rotational thromboelastometry (ROTEM) is a point‐of‐care device used to monitor …

Are viscoelastometric assays of old generation ready for disposal? Comment on Volod et al. Viscoelastic hemostatic assays: A primer on legacy and new generation …

M Bareille, T Lecompte, F Mullier, S Roullet - Journal of clinical medicine, 2023 - mdpi.com
With the advent of new viscoelastometric hemostatic assay (VHA) devices, with ready-to-use
cartridge reagents allowing for their use by people without special laboratory skills, the …

Development of Synthetic Platelet‐Activating Hydrogel Matrices to Induce Local Hemostasis

XH Qin, K Labuda, J Chen, V Hruschka… - Advanced Functional …, 2015 - Wiley Online Library
Several hemostatic strategies rely on the use of blood components such as fibrinogen and
thrombin, which suffer from high cost and short shelf‐life. Here, a cost‐effective synthetic …

The non-activated thromboelastometry (NATEM) assay's application among adults and neonatal/pediatric population: A systematic review

P Georgiadou, R Sokou, AG Tsantes, S Parastatidou… - Diagnostics, 2022 - mdpi.com
The non-activated thromboelastometry (NATEM) assay is a point-of-care assay that can
provide a comprehensive insight into the actual hemostatic mechanism. However, there are …